ALEXANDER KAGANOWICZ - Corporate Board Profile

RESEARCH FRONTIERS INC

Filing Date	Source Excerpt
2013-04-30	Alexander Kaganowicz, age 66, has been a shareholder of Research Frontiers since 1998. He is the Board Nominee for Class II director with term expiring at the 2016 Annual Meeting of Stockholders.
2014-04-28	Alexander Kaganowicz, age 67, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company 27s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. ... The following table summarizes compensation paid or awarded to the Company 27s non-management directors in 2013. ... Alexander Kaganowicz ... 68,354
2015-04-28	Alexander Kaganowicz, age 68, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Companys Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees.
2016-04-26	Alexander Kaganowicz, age 69, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Companys Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees.
2017-04-26	Alexander Kaganowicz, age 70, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Companys Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees.
2018-04-18	Alexander Kaganowicz, age 71, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Companys Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. ... The following table summarizes compensation paid or awarded to the Companys non-management directors in 2017. ... Alexander Kaganowicz 35,000 7,244 42,244
2019-04-29	Alexander Kaganowicz, age 72, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company27s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees.
2020-04-29	Alexander Kaganowicz, age 73, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company27s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. Non-management directors of the Company each received compensation for service on the Board in 2019 in a combination of an option award granted in June 2019 and December 2019 for a total of 75,000 shares of Common Stock of the Company (having an estimated value at the time of grant of $121,760 and a cash fee paid in January 2019 of $35,000. The following table summarizes compensation paid or awarded to the Company27s non-management directors in 2019. Alexander Kaganowicz 35,000 121,760 156,760
2021-04-29	Alexander Kaganowicz, age 74, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company’s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. ... The current members of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee are Messrs. Daigle, Kaganowicz and Settle. ... Non-management directors of the Company each received compensation for service on the Board in 2020 in an option award granted in December 2020 for a total of 40,000 shares of Common Stock of the Company (having an estimated value at the time of grant of $66,000 and a cash fee paid in January 2020 of $35,000. ... Alexander Kaganowicz: Fees Paid in Cash $35,000, Stock/Option Awards $66,000, Total $101,000.
2022-04-29	Alexander Kaganowicz, age 75, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company27s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. ... The following table summarizes compensation paid or awarded to the Company27s non-management directors in 2021. ... Alexander Kaganowicz 35,000 cash, 44,000 stock/options, total 79,000.
2023-04-28	Alexander Kaganowicz, age 76, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company27s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. ... Non-management directors of the Company each received compensation for service on the Board in 2022 in an option award granted in December 2022 for a total of 45,000 shares of Common Stock of the Company (having an estimated value at the time of grant of $58,950 and a cash fee paid in January 2023 of $40,000. The following table summarizes compensation paid or awarded to the Company27s non-management directors in 2022. ... Alexander Kaganowicz 40,000 58,950 98,950
2024-04-26	Alexander Kaganowicz, age 77, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company’s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees.